HSBA

1,439.8

+0.31%↑

BARC

515.9

+0.96%↑

LLOY

109.15

+0.6%↑

STAN

2,043

-0.78%↓

FERG.UK

17,950

+1.36%↑

HSBA

1,439.8

+0.31%↑

BARC

515.9

+0.96%↑

LLOY

109.15

+0.6%↑

STAN

2,043

-0.78%↓

FERG.UK

17,950

+1.36%↑

HSBA

1,439.8

+0.31%↑

BARC

515.9

+0.96%↑

LLOY

109.15

+0.6%↑

STAN

2,043

-0.78%↓

FERG.UK

17,950

+1.36%↑

HSBA

1,439.8

+0.31%↑

BARC

515.9

+0.96%↑

LLOY

109.15

+0.6%↑

STAN

2,043

-0.78%↓

FERG.UK

17,950

+1.36%↑

HSBA

1,439.8

+0.31%↑

BARC

515.9

+0.96%↑

LLOY

109.15

+0.6%↑

STAN

2,043

-0.78%↓

FERG.UK

17,950

+1.36%↑

Search

ConvaTec Group PLC

Closed

SectorFinance

210 1.55

Overview

Share price change

24h

Current

Min

202.6

Max

210.2

Key metrics

By Trading Economics

Income

-34M

71M

Sales

85M

1.3B

P/E

Sector Avg

29.8

22.989

EPS

0.08

Dividend yield

3.47

Profit margin

5.575

Employees

10,910

EBITDA

57M

338M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+45.4% upside

Dividends

By Acuity

Dividend yield

Sector Avg

3.47%

4.69%

Next Earnings

4 Aug 2026

Next Ex Dividend date

20 Aug 2026

Market Stats

By TradingEconomics

Market Cap

-793M

4.1B

Previous open

208.45

Previous close

210

News Sentiment

By Acuity

8%

92%

3 / 439 Finance

ConvaTec Group PLC Chart

Past performance is not a reliable indicator of future results.

About ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat